Results 191 to 200 of about 84,355 (327)

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real‐world data from a multicentre study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Methotrexate (MTX) has been a longstanding therapeutic option for mycosis fungoides (MF); however, data on its real‐world effectiveness remain limited. This study aimed to assess real‐world outcomes of oral MTX in the treatment of MF. Data from five referral centres for cutaneous lymphoma in Greece were retrospectively reviewed with the baseline‐ and ...
Vasiliki Nikolaou, Evdoxia Panou, Antonios Tsimpidakis, Ioannis‐Alexios Koumprentziotis, Aikaterini Patsatsi, Marina Siakantaris, Sabine‐Elke Kruger‐Krasagakis, Leonidas Marinos, Elisavet Georgiou, Kyriaki Lampadaki, Aliki Velissari, Athina‐Ioanna Daponte, Aikaterini Doxastaki, Stella Kaliampou, Aristeidis Vaiopoulos, Iliana Konstandinou, Marios Koumourtzis, Eleftheria Lakiotaki, Vassiliki Pappa, Athanasios Tsamaldoupis, Alexander Stratigos, Evangelia Papadavid   +21 more
wiley   +1 more source

Case Report: Cutaneous T-cell lymphoma associated with biologic therapy: three cases and a literature review. [PDF]

Front Med (Lausanne)
Li T, Wang G, Zhang C, Wang W, Li C, Wang Y.   +5 more
europepmc   +1 more source

Co‐existence of cutaneous T‐cell lymphoma and B hairy cell leukemia [PDF]

, 2000
Rossella Paolini, Alessandro Poletti, Emilio Ramazzina, Chiara Menin, Maria Santacatterina, Marco Montagna, Laura Bonaldi, Annarosa Del Mistro, Sergio Zamboni, Emma D’Andrea   +9 more
openalex   +1 more source

Epitheliotropic T-cell lymphoma in Syrian Hamster (Mesocricetus auratus) [PDF]

Lymphomas are neoplasms characterized by the clonal proliferation of malignant lymphocytes, are considered one of the most common tumors recognized in hamsters.
Dacak, DA, De Oliveira, TES, Heurich-Suárez, GM, Maidana, LG, Méndez-Morán, DN, Vetter, JR   +5 more
core   +1 more source

Acneiform type of mogamulizumab‐associated rash

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Inga Hansen‐Abeck, Glenn Geidel, Finn Abeck, Anne Menz, Stefan W. Schneider, Nina Booken   +5 more
wiley   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara‐Pinton, S. Christen‐Zaech, M. Deleuran, M. Dittmann, N. Fosse, K. Gáspár, L. A. A. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, S. Holland, C. G. Mortz, A. Nast, U. Nygaard, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra‐Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, R. N. Werner, C. Flohr   +31 more
wiley   +1 more source

CD38 in the pathobiology of cutaneous T-cell lymphoma and the potential for combination therapeutic intervention. [PDF]

Leukemia
Isabelle C, Boles A, McConnell K, Keller R, Burzinski R, Hutchins Z, Calabretto G, Cheslow L, Xu J, Chakravarti N, Porcu P, Nikbakht N, Mishra A.   +12 more
europepmc   +1 more source

HTLV-II–Associated Cutaneous T-Cell Lymphoma in a Patient with HIV-1 Infection [PDF]

, 2000
Bernard J. Poiesz, Dipak K. Dube, Syamalima Dube, Jayne Love, Lawrence D. Papsidero, Ayşegül Üner, Robert Hutchinson   +6 more
openalex   +1 more source

Erythema annulare centrifugum and Hodgkin lymphoma during pregnancy

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Valentine Horiot, Félix Blaison, Claire Tinevez, Carine Greib, Camille Prot‐Leurent, Jean‐François Viallard, Estibaliz Lazaro, Etienne Rivière   +7 more
wiley   +1 more source

Prognosis of increasing percentages of lesional body surface area in early stage mycosis fungoides

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study identifies a progressive decline in overall survival with each 10% increase in BSA in early‐stage mycosis fungoides. A new BSA cut‐off of 40% is proposed as a significant prognostic factor for patients with patch/plaque‐stage disease, with potential therapeutic consequences.
Juliette M. Kersten, Rosanne Ottevanger, Koen D. Quint, Maarten H. Vermeer, Jelle J. Goeman, Youn Kim, Felicity Evison, Julia J. Scarisbrick, Rein Willemze   +8 more
wiley   +1 more source